Cleared Traditional

K042693 - IV ADMINISTRATION SET B400 SP

K042693 is an FDA 510(k) clearance for IV ADMINISTRATION SET B400 SP, manufactured by Codan US Corp.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K042693 · Codan US Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2004
Decision
21d
Days
Class 2
Risk

K042693 is an FDA 510(k) clearance for the IV ADMINISTRATION SET B400 SP. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Codan US Corp. (Santa Ana, US). The FDA issued a Cleared decision on October 21, 2004 after a review of 21 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Codan US Corp. devices

FDA 510(k) Submission Details - K042693

510(k) Number K042693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2004
Decision Date October 21, 2004
Days to Decision 21 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
108d faster than avg
Panel avg: 129d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 513
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K042693.
BD POSIFLOW POSITIVE DISPLACEMENT VALVE
K050207 · Becton Dickinson Infusion Therapy Systems, Inc. · Apr 2005
SOLUTION ADMINISTRATION WITH LUER ACCESS INJECTION SITE
K042936 · Baxter Healthcare Corp · Nov 2004
IV ADMINISTRATION SETS WITH ULTRABLOCK UV-RESISTANT TUBING
K041490 · B.Braun Medical, Inc. · Oct 2004
Y CLAVE CONNECTOR WITH INTEGRATED CHECK VALVE, MODEL XI-3432
K042182 · Icu Medical, Inc. · Sep 2004
TEGO NEEDLE FREE ACCESS ACCESS DEVICE
K040710 · Icu Medical, Inc. · Aug 2004
PUNCTUR-GUARD WINGED SET FOR BLOOD COLLECTION, MODEL 5118
K041410 · Icu Medical, Inc. · Jul 2004